Accelera Innovations Stock Today
| ACNV Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 50
|
Accelera Innovations is selling for under 1.0E-4 as of the 30th of November 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Accelera Innovations has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Accelera Innovations are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. Accelera Innovations, Inc. was founded in 2008 and is based in Colorado Springs, Colorado. Accelera Innovations is traded on OTC Exchange in the United States.. The company has 81.41 M outstanding shares. More on Accelera Innovations
Follow Valuation Daily Balance Of Power
Check how we calculate scores
Accelera Pink Sheet Highlights
| Chairman of the Board | Geoffrey Thompson |
| Old Name | Accor SA |
| Business Concentration | Health Information Services, Healthcare (View all Sectors) |
Accelera Innovations [ACNV] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 203.52 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Accelera Innovations's market, we take the total number of its shares issued and multiply it by Accelera Innovations's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Accelera Innovations conducts business under Healthcare sector and is part of Health Information Services industry. The entity has 81.41 M outstanding shares.
Accelera Innovations currently holds about 280.81 K in cash with (214.81 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Accelera Innovations Probability Of Bankruptcy
Accelera Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Accelera Innovations without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Accelera Innovations Corporate Executives
Elected by the shareholders, the Accelera Innovations' board of directors comprises two types of representatives: Accelera Innovations inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accelera. The board's role is to monitor Accelera Innovations' management team and ensure that shareholders' interests are well served. Accelera Innovations' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accelera Innovations' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jimmy Lacaba | COO of Advance Lifecare | Profile |
Additional Tools for Accelera Pink Sheet Analysis
When running Accelera Innovations' price analysis, check to measure Accelera Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelera Innovations is operating at the current time. Most of Accelera Innovations' value examination focuses on studying past and present price action to predict the probability of Accelera Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelera Innovations' price. Additionally, you may evaluate how the addition of Accelera Innovations to your portfolios can decrease your overall portfolio volatility.